Cargando…

Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda

BACKGROUND: Lack of adequate detail compromises analysis of reported suspected adverse drug reactions (ADRs). We investigated how comprehensively Ugandan healthcare professionals (HCPs) described their most recent previous-month suspected ADR, and determined the characteristics of HCPs who provided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiguba, Ronald, Karamagi, Charles, Waako, Paul, Ndagije, Helen B., Bird, Sheila M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408100/ https://www.ncbi.nlm.nih.gov/pubmed/25905889 http://dx.doi.org/10.1371/journal.pone.0123974

Ejemplares similares

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants
por: Kiguba, Ronald, et al.
Publicado: (2014)

Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda
por: Kiguba, Ronald, et al.
Publicado: (2015)

Antibiotic‐associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study
por: Kiguba, Ronald, et al.
Publicado: (2017)

Adverse Drug Reaction Onsets in Uganda’s VigiBase(®): Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses
por: Kiguba, Ronald, et al.
Publicado: (2018)

Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2017)

Herbal medicine use and linked suspected adverse drug reactions in a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2016)

Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
por: Kiguba, Ronald, et al.
Publicado: (2022)

Quality of care for adult in-patients with malaria in a tertiary hospital in Uganda
por: Kiguba, Ronald, et al.
Publicado: (2021)

Extensive antibiotic prescription rate among hospitalized patients in Uganda: but with frequent missed-dose days
por: Kiguba, Ronald, et al.
Publicado: (2016)

Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study
por: Kiguba, Ronald, et al.
Publicado: (2023)

Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
por: Ndagije, Helen Byomire, et al.
Publicado: (2020)

Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors
por: Asio, Lillian, et al.
Publicado: (2023)

Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study
por: Kiguba, Ronald, et al.
Publicado: (2022)

Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study
por: Zakumumpa, Henry, et al.
Publicado: (2022)

Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance
por: Nambasa, Victoria, et al.
Publicado: (2020)

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
por: Zakumumpa, Henry, et al.
Publicado: (2021)

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
por: Kiguba, Ronald, et al.
Publicado: (2020)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactions
por: Kuula, Laura S.M., et al.
Publicado: (2022)

An Evaluation of Antibiotic Prescription Rationality at Lower Primary Healthcare Facilities in Three Districts of South-Western Uganda
por: Nantongo, Hanifah, et al.
Publicado: (2022)

Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda
por: Ndagije, Helen, et al.
Publicado: (2015)

The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study
por: Ndagije, Helen Byomire, et al.
Publicado: (2019)

Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018)

Suspected adverse reaction to erysipelas vaccine in sheep
por: Bidewell, Cornelia, et al.
Publicado: (2020)

A Case of Serious Adverse Reaction Following Rabies Vaccination
por: Kang, Zhilin, et al.
Publicado: (2018)

Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda
por: Namuddu, Betty, et al.
Publicado: (2011)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu, Sarah, et al.
Publicado: (2013)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

The Necessity of a Nationwide Surveillance System of Serious BCG Adverse Reactions
por: Cho, Hye-Kyung
Publicado: (2019)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Serious adverse drug reactions at two children’s hospitals in South Africa
por: Mouton, Johannes P., et al.
Publicado: (2020)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

A serious adverse surgical event: Management of suspected HSV-1 keratitis in a donor cornea
por: Kaye, Rebecca, et al.
Publicado: (2017)

The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study
por: Ndagije, Helen Byomire, et al.
Publicado: (2018)

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers
por: Williams, S. Elizabeth, et al.
Publicado: (2013)

Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
por: KC, Santosh, et al.
Publicado: (2013)

Suspected Yellow Fever Case Determined to be Adverse Vaccine Reaction
por: Ding, Sheng, et al.
Publicado: (2019)

An analysis of serious adverse drug reactions at a tertiary care teaching hospital
por: Prajapati, Kinjal, et al.
Publicado: (2016)

Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions
por: Yang, Jincheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5o84d6jblg1slt4br3b7m90qu4